Welcome to India's first Website with complete information on Infectious deseases, Vaccines, Immunisation and Immunoglobulins. + + + Become a registered member of the site and recieve latest balanced information from the world of Vaccines.

 List of State Immunization Officers in the Countrynew

 

List of Polio Vaccination Centers in Delhi for International Travelers.  new

 
 

Polio Vaccination for Travelers  

 
PDF Print E-mail

Rotavirus vaccines projected to save more than 2.4 million lives in developing countries by 2030

Special supplement to the journal Vaccine provides critical insights to maximize vaccine impact in low-resource settings

Rotavirus vaccines offer the best hope for preventing severe rotavirus disease and the deadly dehydrating diarrhea that it causes, particularly in low-resource settings where treatment for rotavirus infection is limited or unavailable, according to studies published in the April 2012 special supplement to the journal Vaccine. The special supplement, “Rotavirus Vaccines for Children in Developing Countries,” summarizes data on the performance of rotavirus vaccines to help maximize their impact in developing countries, which stand to experience the greatest overall public health benefit from the introduction of rotavirus vaccines due to their extremely high rates of severe rotavirus disease and death.

 
PDF Print E-mail

Recommendation for the use of Tdap in HCW

 

In India when we talk about vaccination, more often it is meant for children only, but we forget about the adolescent, Adults, Sick adults Geriatric and above all the respected health care workers who expose their lives to micro-organism and help the community.

We forget about these Health Care Workers (HCW) and have no time to think about them and talk on this issue, not even the Gov’t of India bothers.

Followings are the provisional recommendation for the use of Tdap in HCW (HCP)
 
PDF Print E-mail

 

Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial

The FUTURE I/II Study Group

Correspondence to: J Dillner, Department of Medical Microbiology, Lund University, Malmö University Hospital, SE-20502 Malmö, Sweden This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Abstract

Objectives To evaluate the prophylactic efficacy of the human papillomavirus (HPV) quadrivalent vaccine in preventing low grade cervical, vulvar, and vaginal intraepithelial neoplasias and anogenital warts (condyloma acuminata).

 
PDF Print E-mail

Temperature Sensitivity of the Diphtheria Containing Vaccines

 

Immunization managers can improve the efficiency of immunization programmes through enhancing their knowledge of a vaccine’s stability.

Vaccine management is basically all the actions related to handling of vaccines at the country level from the moment they arrive until the moment they are used. These include arrival and acceptance procedures, appropriate temperature monitoring, ensuring sufficient storage volume, maintaining standards of buildings, equipment and vehicles, effective stock management, vaccine delivery systems as well as effective use of policies such as the multidose vial policy (MDVP) and the use of vaccine vial monitors (VVM).

The World Health Organization (WHO) and UNICEF offer standard tools to effectively monitor management performance of vaccine stores and the vaccine management system in a country (World Health Organization, 2010).

 
PDF Print E-mail

FDA Licenses Sanofi Pasteur’s New Influenza Vaccine Delivered by Intradermal Microinjection

– Fluzone® Intradermal (Influenza Virus Vaccine) first to offer an immunization option with 90 percent smaller needle –

Swiftwater, Pa — May 10, 2011 /PRNewswire/ —

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today the U.S. Food and Drug Administration (FDA) has approved the company’s supplemental biologics license application (sBLA) for licensure of Fluzone Intradermal (Influenza Virus Vaccine). Fluzone Intradermal vaccine is indicated for active immunization of adults 18 through 64 years of age against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine.
 
PDF Print E-mail

Antivaccine lobby resists introduction of Hib vaccine in India

A campaign against the Haemophilus influenzae type b (Hib) vaccine in India launched by some medical professionals has delayed a government plan to introduce the vaccine through its free national immunisation programme for children.

The health ministry had last year announced that it would replace the standard vaccine for diphtheria, pertussis, and tetanus with a pentavalent vaccine that would also protect children against hepatitis B and Hib.

The Global Alliance for Vaccines and Immunisation (GAVI), after consultation with the Indian health ministry, had pledged in August 2009 a grant of $165m (£110m;  135m) to roll out the new vaccine to cover 10 million children in 10 of India’s 28 states in 2010.

The Hib organism, which can cause severe bacterial meningitis and pneumonia, is estimated to kill more than 370 000 children worldwide each year, GAVI said. Nearly 20% of these deaths occur in India.
 
PDF Print E-mail

Novel H1N1 Influenza: Resources for Clinicians

 

 

Guidance for Patient Management

 

Guidance for Specific Settings